RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles

Displaying items 12-22
  • Pfizer walks away from AstraZeneca takeover attempt

    Pfizer walks away from AstraZeneca takeover attempt
    Pfizer Inc. said Monday that it had abandoned its current attempt to buy AstraZeneca PLC for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British...
  • Pfizer abandons AstraZeneca takeover attempt after rejection

    Pharmaceutical giant Pfizer Inc. has abandoned its effort to buy British rival AstraZeneca for $117 billion in what would have been the biggest deal ever in the drug industry. The offer represented "full value" for AstraZeneca, the New York drug maker...
  • European stock index reaches 6-year high; Italian, Spanish bonds rise

    European stock index reaches 6-year high; Italian, Spanish bonds rise
    While U.S. and British markets were closed for holidays Monday, stocks rose in Europe. A benchmark of European equities climbed to a six-year high, while Italian and Spanish bonds advanced as policymakers said they would take steps to support economic...
  • Pfizer's interest in AstraZeneca worries Maryland

    Pfizer's interest in AstraZeneca worries Maryland
    Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina. Maryland officials don't want this state to join that list. After Pfizer declared its desire to buy AstraZeneca — which...
  • Is this how we'll cure cancer?

    Is this how we'll cure cancer?
    For 85% of kids with a terrible cancer called acute lymphoblastic leukemia, chemotherapy is a cure-but not for Emily Whitehead. Diagnosed at 5, she suffered an infection from her first round of chemo and nearly lost her legs. Then the cancer came back;...
  • Drug maker Pfizer says profit fell 15% as it pursues AstraZeneca

    Pharmaceutical giant Pfizer Inc. reported its first quarter earnings fell 15% as the company struggled with expiring patents and increasing competition from generic drugs. The disappointing news added urgency to the New York company's efforts to acquire...
  • Maryland, Del. governors concerned about Pfizer's proposed takeover of AstraZeneca

    Maryland, Del. governors concerned about Pfizer's proposed takeover of AstraZeneca
    Gov. Martin O'Malley and Delaware Gov. Jack Markell sent a joint letter to Pfizer Thursday expressing concerns about its proposed $106 billion acquisition of pharmaceutical firm AstraZeneca, which employs thousands in both states. The governors said...
  • Saint Agnes to use grant to target African-American women with heart disease

    Saint Agnes to use grant to target African-American women with heart disease
    Saint Agnes Hospital will work with local churches to screen for heart disease, using a $244,455 grant from The AstraZeneca HealthCare Foundation. The hospital announced Thursday that it had received the award. The screening program will focus on...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • FDA says new cholesterol drugs may not need outcome studies

    FDA says new cholesterol drugs may not need outcome studies
    Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
  • Drug maker Merck laying off 8,500 in strategy overhaul

    Drug maker Merck laying off 8,500 in strategy overhaul
    Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.  That's on top of a previous announcement that the Whitehouse Station, N.J.-based...